enGene Holdings Inc. (ENGN) vs NRx Pharmaceuticals, Inc. (NRXP)

A side-by-side comparison of enGene Holdings Inc. and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ENGN

enGene Holdings Inc.

$121M

$1.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NRXP

NRx Pharmaceuticals, Inc.

$127M

$2.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ENGN vs NRXP

growth of $100 · dividends reinvested · last 3y

ENGN -90.7% (-54.6%/yr)NRXP -13.0% (-4.5%/yr)NRXP compounded faster over this window

Log scale — wide-divergence pair

ENGN NRXP

ENGN vs NRXP: by the numbers

•NRXP is the larger company ($127M vs $121M market cap).
•Both run net losses; ENGN's is the smaller (0.00% vs -691.81% net margin).

Metrics side by side

Valuation

Metric	ENGN	NRXP
P/S ratio	N/A	37.50
P/B ratio	0.52	N/A

Profitability

Metric	ENGN	NRXP
Gross margin	0.00%	58.78%
Operating margin	0.00%	-1324.41%
Net margin	0.00%	-691.81%
ROE	-2.13%	N/A
ROIC	-1.78%	N/A

Growth (annualized)

Metric	ENGN	NRXP
Total return CAGR (5Y)	N/A	-49.61%

Go deeper

Full ENGN analysis Full NRXP analysis Interactive comparison tool

Dig into the metrics

enGene ROE NRx Pharmaceuticals ROE enGene operating margin NRx Pharmaceuticals operating margin enGene revenue growth NRx Pharmaceuticals revenue growth enGene free cash flow NRx Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.